Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be confronted now and in the future. These insights will be of great value to decision-makers, policy-makers and indeed to all stakeholders affected by a myriad of local, regional or global threats.
Cemil Alyanak, Daniel Krewski, Greg Paoli, and the entire RSI team have been hard at work for over a year preparing for this launch. According to Dr. Krewski, “There has never been a more opportune time for risk scientists to contribute to the mitigation of the growing list of risks that we face on a daily basis.”
RSI considers this initially self-funded effort to be a critical public interest project. Cemil Alyanak, who planted the seed to this project says: “Large national and international datasets are crucial to determining future risks. So too is the input of millions of individuals who observe and face conditions of risk daily. If we can successfully tap into what they see, experience and feel, we will have unlocked a treasure chest of useable data that, when properly analyzed, can potentially identify risks on the horizon long before they occur.”
Currently, the Census, while open to the entire world, is only available in English. The French translation will be posted shortly with others to follow.
It’s free, it’s a public service, and it helps us Anticipate Risks Together!
The Global Risk Census: https://riskcensus.org
Posted in RSI News
More RSI News
Quinolones and risk of acute liver failure
Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…
Read News ItemUS FDA FAERS and quinolones
Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…
Read News ItemAdvancing Toxicity Testing webinar
The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century…
Read News ItemUSC appoints Dr. Mattison distinguished professor
Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in…
Read News Item